Table 3 Comparison of HRCT findings between pSS patients with and without ILD progression.

From: Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren’s syndrome

 

Total pSS-ILD (n = 39)

pSS-ILD with progression (n = 19)

pSS-ILD without progression (n = 20)

P-value

Baseline CT findings

 UIP pattern, n (%)

7 (17.9)

6 (31.6)

1 (5.0)

0.044a

 OP pattern, n (%)

3 (7.7)

0 (0.0)

3 (15.0)

0.231a

 Total disease extent

23.0 (15.5, 34.0)

23.0 (15, 36)

23.0 (15.5, 31.0)

1.000b

 Extent of GGO

5.4 (3.1, 8.1)

5.1 (2.8,7.9)

6.4 (3.9, 8.5)

0.391b

 Extent of fine reticulation

8.9 (6.3, 12.4)

8.0 (6.2, 11.9)

9.1 (7.4, 12.3)

0.708b

 Extent of coarse reticulation

5.34 (0.1, 19.0)

8.3 (1.1–71.5)

1.7 (0.2, 1.59)

0.385b

 Presence of HC, n (%)

18 (46.1)

11 (57.9)

7 (35.0)

0.248a

 Coarseness score of fibrosis (0–15)

5 (4, 8)

5 (4, 10)

5 (3.7–7.2)

0.343b

 Scores of traction bronchiectasis (0–15)

7 (3, 9.5)

7 (3, 11)

6.5 (2.7–9.0)

0.391b

Last follow-up CT findings

 Total disease extent

28.0 (19.0, 40.5)

30 (23.0, 46.0)

22.5 (14.0, 32.5)

0.036b

 Extent of GGO

3.8 (1.5, 6.4)

3.01 (1.5, 5.2)

5.13 (2.2, 7.0)

0.327b

 Extent of fine reticulation

9.3 (7.34, 12.9)

9.24 (8.3, 12.9)

9.52 (4.4, 12.8)

0.418b

 Extent of coarse reticulation

11.7 (1.8, 26.6)

19.8 (5.7, 31.2)

4.8 (0.28, 23.8)

0.025b

 Presence of HC, n (%)

27 (69.2)

15 (78.9)

12 (60.0)

0.476a

 Coarseness score of fibrosis (0–15)

7 (5, 10.5)

9 (5, 13)

6.5 (3.75, 9.0)

0.031b

 Scores of traction bronchiectasis (0–15)

8 (5, 12)

11 (6, 13)

6.5 (3.7, 10.0)

0.066b

Absolute changes of HRCT scores between baseline and last follow-up

 Total disease extent

3 (0–9)

9 (4–12)

0 (0–2.0)

 < 0.001b

 Extent of GGO

-1.2 (-3.4, -0.2)

-1.3 (-4.1,-0.0)

-1.1 (-3.4,-0.5)

0.893b

 Extent of fine reticulation

0.3 (-1.1, 1.6)

0.4 (-0.1, 3.5)

0.2 (-0.8, 0.9)

0.425b

 Extent of coarse reticulation

3.7 (0.6–11.2)

9.12 (3.6, 15.1)

1.25 (0, 4.2)

0.003b

 Coarseness score of fibrosis (0–15)

2 (0, 3)

2 (1, 4)

1 (0, 2)

0.189b

 Scores of traction bronchiectasis (0–15)

0 (1, 3)

3 (1, 3)

0.5 (0, 2)

0.011b

Annual changes of HRCT scores

Total disease extent/year

0.7 (0, 2.6)

2.4 (0.5, 3.7)

0.0 (0.0, 0.7)

0.001b

Extent of GGO/year

-0.4 (-0.9, -0.5)

-0.2 (-0.7, -0.0)

-0.5 (-1.1, -0.2)

0.118b

Extent of fine reticulation/year

0.0 (-0.6, 3.5)

0.0 (-0.4, 0.6)

0.0 (-0.9, 0.4)

0.708b

Extent of coarse reticulation/year

0.4 (0.0, 0.7)

1.6 (0.6, 3.9)

0.5 (0.0, 2.0)

0.021b

Coarseness score of fibrosis/year

0.4 (0.0, 0.7)

0.5 (0.1, 0.7)

0.3 (0.0, 0.6)

0.461b

Scores of traction bronchiectasis/year

0.3 (0.0, 0.7)

0.5 (0.1, 0.7)

0.1 (0.0, 0.7)

0.223b

  1. Values are expressed as median (Q1, Q3) unless otherwise stated. Intergroup comparisons were conducted using aFisher’s exact test and bMann–Whitney U test. pSS: primary Sjogren’s syndrome, ILD: interstitial lung disease, HRCT: high resolution computed tomography, UIP: usual interstitial pneumonia, OP: organizing pneumonia, GGO: ground-glass opacities, HC: honeycombing.
  2. Significant values are in bold.